Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ

Jeffrey S. Mogil, Judith E. Grisel, Ge Zhangs, John Belknap, David Grandy

Research output: Contribution to journalArticle

193 Citations (Scopus)

Abstract

Orphanin FQ (OFQ) is the recently isolated endogenous ligand for the orphan opioid-like receptor, LC132. Initial reports suggested that OFQ increased pain sensitivity when injected intracerebroventricularly (i.c.v.) in mice. However, we have recently demonstrated that OFQ is instead an anti-opioid peptide that reverses morphine- and opioid-mediated stress-induced antinociception. Morphine binds to multiple opioid receptor types (μ, δ, and κ). The present study was designed to examine specific interactions of OFQ with antinociception mediated by each receptor type. To this end, mice were administered i.c.v. cocktails containing either vehicle or OFQ (10 nmol) and a μ-specific ([D-Ala2,N-Me-Phe4-Gly-ol]enkephalin; DAMGO; 0-0.1 nmol), δ-specific ([D-Pen2, D-Pen5]enkephalin; DPDPE; 0-50 nmol), or κ-specific (U-50,488H; 0-1000 nmol) agonist. As we have shown previously, OFQ alone had no effect on nociceptive sensitivity. OFQ was, however, able to completely block supraspinal antinociception produced by all three receptor type-selective agonists. We conclude, therefore, that OFQ functionally antagonizes μ (and (opioid receptors, and may play a general role in opioid modulation.

Original languageEnglish (US)
Pages (from-to)131-134
Number of pages4
JournalNeuroscience Letters
Volume214
Issue number2-3
DOIs
StatePublished - Aug 23 1996

Fingerprint

Opioid Analgesics
Opioid Receptors
D-Penicillamine (2,5)-Enkephalin
Morphine
(trans)-Isomer 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Opioid Peptides
nociceptin
Enkephalins
Ligands
Pain

Keywords

  • Anti-opiate
  • Delta
  • Kappa
  • LC132 receptor
  • Mu
  • Orphanin FQ
  • Pain inhibition

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Mogil, J. S., Grisel, J. E., Zhangs, G., Belknap, J., & Grandy, D. (1996). Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neuroscience Letters, 214(2-3), 131-134. https://doi.org/10.1016/0304-3940(96)12917-7

Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. / Mogil, Jeffrey S.; Grisel, Judith E.; Zhangs, Ge; Belknap, John; Grandy, David.

In: Neuroscience Letters, Vol. 214, No. 2-3, 23.08.1996, p. 131-134.

Research output: Contribution to journalArticle

Mogil, JS, Grisel, JE, Zhangs, G, Belknap, J & Grandy, D 1996, 'Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ', Neuroscience Letters, vol. 214, no. 2-3, pp. 131-134. https://doi.org/10.1016/0304-3940(96)12917-7
Mogil, Jeffrey S. ; Grisel, Judith E. ; Zhangs, Ge ; Belknap, John ; Grandy, David. / Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. In: Neuroscience Letters. 1996 ; Vol. 214, No. 2-3. pp. 131-134.
@article{a181280a30804b0ab86c48473e66f216,
title = "Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ",
abstract = "Orphanin FQ (OFQ) is the recently isolated endogenous ligand for the orphan opioid-like receptor, LC132. Initial reports suggested that OFQ increased pain sensitivity when injected intracerebroventricularly (i.c.v.) in mice. However, we have recently demonstrated that OFQ is instead an anti-opioid peptide that reverses morphine- and opioid-mediated stress-induced antinociception. Morphine binds to multiple opioid receptor types (μ, δ, and κ). The present study was designed to examine specific interactions of OFQ with antinociception mediated by each receptor type. To this end, mice were administered i.c.v. cocktails containing either vehicle or OFQ (10 nmol) and a μ-specific ([D-Ala2,N-Me-Phe4-Gly-ol]enkephalin; DAMGO; 0-0.1 nmol), δ-specific ([D-Pen2, D-Pen5]enkephalin; DPDPE; 0-50 nmol), or κ-specific (U-50,488H; 0-1000 nmol) agonist. As we have shown previously, OFQ alone had no effect on nociceptive sensitivity. OFQ was, however, able to completely block supraspinal antinociception produced by all three receptor type-selective agonists. We conclude, therefore, that OFQ functionally antagonizes μ (and (opioid receptors, and may play a general role in opioid modulation.",
keywords = "Anti-opiate, Delta, Kappa, LC132 receptor, Mu, Orphanin FQ, Pain inhibition",
author = "Mogil, {Jeffrey S.} and Grisel, {Judith E.} and Ge Zhangs and John Belknap and David Grandy",
year = "1996",
month = "8",
day = "23",
doi = "10.1016/0304-3940(96)12917-7",
language = "English (US)",
volume = "214",
pages = "131--134",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2-3",

}

TY - JOUR

T1 - Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ

AU - Mogil, Jeffrey S.

AU - Grisel, Judith E.

AU - Zhangs, Ge

AU - Belknap, John

AU - Grandy, David

PY - 1996/8/23

Y1 - 1996/8/23

N2 - Orphanin FQ (OFQ) is the recently isolated endogenous ligand for the orphan opioid-like receptor, LC132. Initial reports suggested that OFQ increased pain sensitivity when injected intracerebroventricularly (i.c.v.) in mice. However, we have recently demonstrated that OFQ is instead an anti-opioid peptide that reverses morphine- and opioid-mediated stress-induced antinociception. Morphine binds to multiple opioid receptor types (μ, δ, and κ). The present study was designed to examine specific interactions of OFQ with antinociception mediated by each receptor type. To this end, mice were administered i.c.v. cocktails containing either vehicle or OFQ (10 nmol) and a μ-specific ([D-Ala2,N-Me-Phe4-Gly-ol]enkephalin; DAMGO; 0-0.1 nmol), δ-specific ([D-Pen2, D-Pen5]enkephalin; DPDPE; 0-50 nmol), or κ-specific (U-50,488H; 0-1000 nmol) agonist. As we have shown previously, OFQ alone had no effect on nociceptive sensitivity. OFQ was, however, able to completely block supraspinal antinociception produced by all three receptor type-selective agonists. We conclude, therefore, that OFQ functionally antagonizes μ (and (opioid receptors, and may play a general role in opioid modulation.

AB - Orphanin FQ (OFQ) is the recently isolated endogenous ligand for the orphan opioid-like receptor, LC132. Initial reports suggested that OFQ increased pain sensitivity when injected intracerebroventricularly (i.c.v.) in mice. However, we have recently demonstrated that OFQ is instead an anti-opioid peptide that reverses morphine- and opioid-mediated stress-induced antinociception. Morphine binds to multiple opioid receptor types (μ, δ, and κ). The present study was designed to examine specific interactions of OFQ with antinociception mediated by each receptor type. To this end, mice were administered i.c.v. cocktails containing either vehicle or OFQ (10 nmol) and a μ-specific ([D-Ala2,N-Me-Phe4-Gly-ol]enkephalin; DAMGO; 0-0.1 nmol), δ-specific ([D-Pen2, D-Pen5]enkephalin; DPDPE; 0-50 nmol), or κ-specific (U-50,488H; 0-1000 nmol) agonist. As we have shown previously, OFQ alone had no effect on nociceptive sensitivity. OFQ was, however, able to completely block supraspinal antinociception produced by all three receptor type-selective agonists. We conclude, therefore, that OFQ functionally antagonizes μ (and (opioid receptors, and may play a general role in opioid modulation.

KW - Anti-opiate

KW - Delta

KW - Kappa

KW - LC132 receptor

KW - Mu

KW - Orphanin FQ

KW - Pain inhibition

UR - http://www.scopus.com/inward/record.url?scp=0030598929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030598929&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(96)12917-7

DO - 10.1016/0304-3940(96)12917-7

M3 - Article

C2 - 8878101

AN - SCOPUS:0030598929

VL - 214

SP - 131

EP - 134

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2-3

ER -